10月9日 - ** 药物开发商Nurix Therapeutics NRIX.O股价在延时交易中下跌7.1%至10.29美元
* (link) * 根据LSEG汇编的数据，该公司第三季度营收为789万美元，分析师预计为1674万美元。
** 公司公布第三季度净亏损为每股1.03美元，而预计净亏损为每股84美分
** 截至8月31日，现金、现金等价物和有价证券为4.288亿美元
** 包括盘中走势在内，该股今年累计下跌 42.4
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.